Browse Indicators

Indicator title
Number of pregnant women attending ANC at least once during the reporting period
Knowledge of a formal source of condoms among young people
Proportion of health care and congregate settings that have a TB infection control policy
Percentage of adults and children enrolled in HIV care and eligible for co-trimoxazole (CTX) prophylaxis (according to national guidelines) currently receiving CTX prophylaxis
Comprehensive HIV/AIDS care and support policies, strategies and guidelines
Reduction in Mother-to-child Transmission
Existence of guidelines for the prevention of HIV infection in infants and young children
Number of drug regimes distributed
Number of men reported with urethral discharge in the past 12 months
Provision of life-skills-based HIV/AIDS education in schools
Number of women and children aged 15 and older received testing and counselling in VCT sites in the past 12 months and know their results
Percentage of health facilities dispensing ARV that experienced a stock-out of at least one required ARV in the last 12 months [disaggregated by sector (public, private)]
Safe sexual behaviour among young people
Number of needle and syringe programme (NSP) sites
Proportion of HIV-positive clients given treatment for latent TB infection
Capacity to provide basic counselling and testing and to manage clinical services for HIV/AIDS
Young people who have a sexually transmitted infection
Percentage of health facilities that provide virological testing services (e.g. PCR) for diagnosis of HIV in infants on site or from dried blood spots (DBS)
Condom use among young people who had higher-risk sex in the preceding year
National HIV/AIDS policy address links between TB and HIV
Number of adults and children with HIV enrolled in HIV care
PMTCT services that refer to care and support facilities
Percentage of HIV-infected pregnant women assessed for eligibility for antiretroviral therapy (CD4 count or clinical staging)
Percent of facilities with a fully functional T&C service centre
Number of adults newly enrolled in pre-antiretroviral therapy (pre-ART) during the reporting period